Status: In progress

In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation

  • Deadline to file a claim: 02/17/2024
  • Proof of Purchase Required: Yes
  • Potential Individual Reward: Varies
  • Total Settlement Amount: $30 million
  • Locations
    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • Colorado
    • Delaware
    • District of Columbia
    • California
    • Florida
    • Georgia
    • Hawaii
    • Idaho
    • Illinois
    • Kansas
    • Nebraska
    • Kentucky
    • Louisiana
    • Maine
    • Maryland
    • Massachusetts
    • Michigan
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nevada
    • New Hampshire
    • New Jersey
    • Connecticut
    • New Mexico
    • New York
    • North Carolina
    • North Dakota
    • Oklahoma
    • Oregon
    • Pennsylvania
    • Rhode Island
    • South Carolina
    • South Dakota
    • Tennessee
    • Texas
    • Utah
    • Vermont
    • Virginia
    • Washington
    • West Virginia
    • Wisconsin
    • Wyoming

Status: In progress

In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation

  • Deadline to file a claim: 02/17/2024
  • Proof of Purchase Required: Yes
  • Potential Individual Reward: Varies
  • Total Settlement Amount: $30 million
  • Locations
    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • Colorado
    • Delaware
    • District of Columbia
    • California
    • Florida
    • Georgia
    • Hawaii
    • Idaho
    • Illinois
    • Kansas
    • Nebraska
    • Kentucky
    • Louisiana
    • Maine
    • Maryland
    • Massachusetts
    • Michigan
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nevada
    • New Hampshire
    • New Jersey
    • Connecticut
    • New Mexico
    • New York
    • North Carolina
    • North Dakota
    • Oklahoma
    • Oregon
    • Pennsylvania
    • Rhode Island
    • South Carolina
    • South Dakota
    • Tennessee
    • Texas
    • Utah
    • Vermont
    • Virginia
    • Washington
    • West Virginia
    • Wisconsin
    • Wyoming

Status: In progress

In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation

  • Deadline to file a claim: 02/17/2024
  • Proof of Purchase Required: Yes
  • Potential Individual Reward: Varies
  • Total Settlement Amount: $30 million
  • Locations
    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • Colorado
    • Delaware
    • District of Columbia
    • California
    • Florida
    • Georgia
    • Hawaii
    • Idaho
    • Illinois
    • Kansas
    • Nebraska
    • Kentucky
    • Louisiana
    • Maine
    • Maryland
    • Massachusetts
    • Michigan
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nevada
    • New Hampshire
    • New Jersey
    • Connecticut
    • New Mexico
    • New York
    • North Carolina
    • North Dakota
    • Oklahoma
    • Oregon
    • Pennsylvania
    • Rhode Island
    • South Carolina
    • South Dakota
    • Tennessee
    • Texas
    • Utah
    • Vermont
    • Virginia
    • Washington
    • West Virginia
    • Wisconsin
    • Wyoming

Status: In progress

In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation

The settlement benefits individuals and entities who indirectly purchased or paid for Suboxone and its AB-rated generic equivalents for themselves, their families, employees, plan participants, beneficiaries or insureds between Dec. 22, 201,1 and Aug. 21, 2023, in certain U.S. states.

  • Deadline to file a claim: 02/17/2024
  • Proof of Purchase Required: Yes
  • Potential Individual Reward: Varies
  • Total Settlement Amount: $30 million
  • Locations
    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • Colorado
    • Delaware
    • District of Columbia
    • California
    • Florida
    • Georgia
    • Hawaii
    • Idaho
    • Illinois
    • Kansas
    • Nebraska
    • Kentucky
    • Louisiana
    • Maine
    • Maryland
    • Massachusetts
    • Michigan
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nevada
    • New Hampshire
    • New Jersey
    • Connecticut
    • New Mexico
    • New York
    • North Carolina
    • North Dakota
    • Oklahoma
    • Oregon
    • Pennsylvania
    • Rhode Island
    • South Carolina
    • South Dakota
    • Tennessee
    • Texas
    • Utah
    • Vermont
    • Virginia
    • Washington
    • West Virginia
    • Wisconsin
    • Wyoming

Status: In progress

In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation

The deadline to submit a claim has passed.

  • Deadline to file a claim: 02/17/2024
  • Proof of Purchase Required: Yes
  • Potential Individual Reward: Varies
  • Total Settlement Amount: $30 million
  • Locations
    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • Colorado
    • Delaware
    • District of Columbia
    • California
    • Florida
    • Georgia
    • Hawaii
    • Idaho
    • Illinois
    • Kansas
    • Nebraska
    • Kentucky
    • Louisiana
    • Maine
    • Maryland
    • Massachusetts
    • Michigan
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nevada
    • New Hampshire
    • New Jersey
    • Connecticut
    • New Mexico
    • New York
    • North Carolina
    • North Dakota
    • Oklahoma
    • Oregon
    • Pennsylvania
    • Rhode Island
    • South Carolina
    • South Dakota
    • Tennessee
    • Texas
    • Utah
    • Vermont
    • Virginia
    • Washington
    • West Virginia
    • Wisconsin
    • Wyoming

By Top Class Actions  |  September 1, 2023

Category: Closed Class Actions

This settlement is closed!

Please see what other class action settlements you might qualify to claim cash from in our Open Settlements directory!

A Suboxone box, representing the Suboxone class action lawsuit settlement.
(Photo Credit: PureRadiancePhoto/Shutterstock)

Update:

  • Final approval for this class action settlement was granted Dec. 4, 2023.
  • Let Top Class Actions know when you receive a check in the comments section below or on our Facebook page.

Indivior agreed to a $30 million antitrust class action lawsuit settlement to resolve claims that it worked with other companies to raise the cost of Suboxone, a treatment for opioid addiction.

The settlement benefits individuals and entities who indirectly purchased or paid for Suboxone and its AB-rated generic equivalents for themselves, their families, employees, plan participants, beneficiaries or insureds between Dec. 22, 2011 and Aug. 21, 2023, in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia.

The antitrust class action lawsuit accused Indivior of conspiring with other companies to raise the price of Suboxone and its generic alternatives. According to the plaintiffs in the case, they were forced to overpay for Suboxone as a result of the antitrust scheme. 

Individor is a pharmaceutical company that specializes in addiction and mental health treatment. 

Indivior hasn’t admitted any wrongdoing but agreed to a $30 million settlement to resolve the antitrust class action lawsuit.

Under the terms of the Suboxone class action settlement, class members can receive a proportional share of the net settlement fund based on the amount they spent in qualifying purchases. Exact payments will vary depending on the number of claims filed and other factors. 

The deadline for exclusion is Oct. 12, 2023. The objection deadline is Oct. 5, 2023.

The final approval hearing for the Suboxone antitrust class action lawsuit settlement is scheduled for Oct. 19, 2023.

In order to receive a settlement payment, class members must submit a valid claim form by Feb. 17, 2024.

Who’s Eligible

Individuals and entities who indirectly purchased or paid for Suboxone and its AB-rated generic equivalents for themselves, their families, employees, plan participants, beneficiaries or insureds between Dec. 22, 2011, and Aug. 21, 2023, in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia

Potential Award

Varies

Proof of Purchase

Records from the class member’s pharmacy showing they purchased Suboxone and its AB‐rated generic equivalents at least once or a note or records from their doctor describing the amount of Suboxone and its AB‐rated generic equivalents prescribed.

Class members may have a claim even if they are not able to provide any of the above claim documentation as long as they provide the certification on the claim form. However, the settlement administrator may ask those who do not provide the above documentation for additional claim documentation after the class member submits their claim form. 

Claim Form

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

02/17/2024

Case Name

In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation, Case No. 2:13-md-02445-MSG, in the U.S. District Court for the Eastern District of Pennsylvania

Final Hearing

10/19/2023

Settlement Website
Claims Administrator

Suboxone End-Payor Antitrust Litigation
c/o A.B. Data, Ltd.
P.O. Box 173080
Milwaukee, WI 53217
[email protected]
877-311-3735

Class Counsel

Kenneth A Wexler
WEXLER BOLEY & ELGERSMA LLP

Steve Shadowen
HILLIARD SHADOWEN LLP

Michael M. Buchman
MOTLEY RICE LLC

Marvin A Miller
MILLER LAW LLC

Jeffrey L Kodroff
SPECTOR ROSEMAN & KODROFF PC

Defense Counsel

Justin Bernick
HOGAN LOVELLS US LLP

Read About More Class Action Lawsuits & Class Action Settlements:

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

272 thoughts onSuboxone indirect purchasers antitrust $30M class action settlement

  1. Brandon puntin says:

    Heres a copy of my email
    Hello Mr. Puntin,

    I am the Project Manager for the Suboxone Settlement, and your review request has been escalated to me.

    Based on my review of your documentation, I am approving your claim as eligible as filed, and nothing further is needed from you at this time. We expect Class Consel to file for distribution sometime in the next 45 days, and await the Court’s approval to calculate the payouts for each eligible claim and distribute.

    Best Regards,
    Marie Christie
    Project Manager

    1. Jay says:

      Who did you email?

  2. LP says:

    People keep saying about getting emails, I have never received one, can anyone elaborate more

    1. J says:

      Did. You get email back before new year asking verify claim that’s the only thing they’ve sent out besides replies to emails sent to them I wouldn’t expect hear anything until late in year or more to be honest not worth it payment is going to be an insult but if they do send payment it’ll be check in mail once everything is approved they have millions claims process and fraudulent ones toss out after that has been approved by court distr payments

      1. Bob Smith says:

        They have the pool of eligible people down to 10,000.

        1. J says:

          I hope so they wouldn’t give me anymore info just still processing and that I’m eligible and still could be few months and has be signed off by judge again

          1. Bob says:

            I used my old law school software to check the docket. AB Data filed a status update stating there are 10k eligible people down from millions. They said they should submit for final approval in early October at the latest.

  3. Flowers says:

    I was told by Mrs Cynthia Rivers when I called the AB data suboxone administration number on the website she said they’ve narrowed down the 10s of millions of fraudulent claims to a few million “valid” claims and well. Do the math it was a 30 million dollar settlement and that’s that. So between her validation of the 6$ amount and basic math WELL were ALL GETTING F**K*D OVER BY INDIVIOR AGAIN…… AND MY TEETH ARE RUINED. 20 YEARS OF HERION ABUSE AND NO ISSUES WITH MY TEETH. TWO YRARS OF SUBOXONE AND I CANT EVEN SMILE ANYMORE. I KNOW THIS ISNT THE VENUE TO VENT MY APOLOGIES BUT YEAH 6$ PER MONTH. ALL INDIVIOR IS ABOUT IS PROFIT AT ABSOLUTELY ANY EXPENSE AND WE ARE THAT EXPENSE THE ONES KEEPING THEM IN BUSINESS

    1. J says:

      I think you got some bad info also you might want to look into tooth decay lawsuit that’s separate also as far as I know amount of payments hasn’t been determined they’re still going through claims and making a list of all eligible claims once that’s done they have show claims admin and it goes back in front of the judge after that they’ll know the amount and when and how by sounds of it probably 2026 the payment would be a check and one time only only not monthly

      1. J says:

        Def not worth waiting on this settlement or even cashing whatever check they do send law firm is the only ones who benefited from this

  4. Jay says:

    Any receive a check yet

    1. Stephanie C says:

      Nope! I heard that the checks won’t go out until November-December of this year.

    2. Petra Flowers Delgado says:

      10 years of Records and ONLY 6$ PER MONTH is what I’m told I will receive but NOT UNTIL JANUARY. WHAT A JOKE. What a terrible company Indivior is it’s like they just toy with us damn carrot on a stick right down the rabbit hole

      1. Lawman says:

        Who told you $6 per month?

    3. Daniel Skeeterbon says:

      Got an email today with explanation of my having $1890.37 in purchases I will get 18% of that in about 90 days via paper check so I’m pretty happy with the outcome after waiting all this time especially with all these fake comments I see.

      1. Kuy says:

        Thats what the email said? I had $82,346.44 in purchases

      2. J says:

        Says the guy posting a fake comment 😂 he’s proof they dk the amounts and haven’t sent anything out also def not getting % of claim doesn’t work like that it’s class action so if 32 million and there over million claims how is one person getting 18% of they submitted not happening.
        We have processed the claim and any supporting documentation that you submitted in In Re: Suboxone (Buprenorphine Hydrochloride and Nalaxone compound) Antitrust Litigation. Based on our review of your claim no further action is needed by you at this time.

        Distribution amounts have not been determined. That information is typically not known until approximately five (5) days before distribution.

        We expect to have a motion filed with the Court in the next few months, and upon Court approval we will be able to distribute to those claimants who are eligible. This process is dependent upon the Court’s timeline. All Court Documents are available to the public and are on the case website for your review, should you need a more detailed Plan of Allocation, or the full settlement Notice, at

    4. Skeet says:

      I got 18% of my total payments I made 1890.37 so that’s like FINALLY damn this dragged on forever it seems like but happy to finally get paid

      1. J says:

        Then got paid something else cause no amounts or payments have been approved there is to many claims for anyone to get anywhere near their claim settlement is only 30 million and there’s millions of claims we will be lucky to get $20

  5. Jay says:

    I say we start a petition for them have return the settlement this firm clearly messed up the entire class action suit been told “few months” since deadline ridiculous not mention millions in fraudulent claims they say they’re processing so that screws the people who actually were scammed of thousands of dollars on this medication

    1. Flowers says:

      I was told by Mrs Cynthia Rivers when I called the AB data suboxone administration number on the website she said they’ve narrowed down the 10s of millions of fraudulent claims to a few million “valid” claims and well. Do the math it was a 30 million dollar settlement and that’s that. So between her validation of the 6$ amount and basic math WELL were ALL GETTING F**K*D OVER BY INDIVIOR AGAIN…… AND MY TEETH ARE RUINED. 20 YEARS OF HERION ABUSE AND NO ISSUES WITH MY TEETH. TWO YRARS OF SUBOXONE AND I CANT EVEN SMILE ANYMORE. I KNOW THIS ISNT THE VENUE TO VENT MY APOLOGIES BUT YEAH 6$ PER MONTH. ALL INDIVIOR IS ABOUT IS PROFIT AT ABSOLUTELY ANY EXPENSE AND WE ARE THAT EXPENSE THE ONES KEEPING THEM IN BUSINESS

      1. Pauline c says:

        This isnt the tooth lawsuit. I think maybe your really confused. Ive contacted them many times and they straight out refuse to discuss amounts. Thats because there still going thru all claims.

1 11 12 13

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.